ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 633

$646K Total Retail Price of All Prescriptions

Rank: 44 out of 633

529 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 529 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 529 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 647 606 91 1 3
LEVOTHYROXINE SODIUM 437 394 66 2 1
FUROSEMIDE 379 361 78 3 6
WARFARIN SODIUM 357 313 53 4 7
AMLODIPINE BESYLATE 351 328 48 5 4
OMEPRAZOLE 349 323 56 6 2
LOSARTAN POTASSIUM 321 297 51 7 17
METFORMIN HCL 314 272 43 8 10
ATORVASTATIN CALCIUM 276 254 49 9 9
LISINOPRIL 273 250 37 10 5
MELOXICAM 271 266* 53 11 23
HYDROCODONE-ACETAMINOPHEN 266 213 59 S3 12 8
TRAMADOL HCL 221 170 32 13 15
CARVEDILOL 192 187* 28 14 18
POTASSIUM CHLORIDE 191 186* 33 15 11
HYDROCHLOROTHIAZIDE 190 185* 35 16 14
SERTRALINE HCL 171 160 26 17 19
LOSARTAN-HYDROCHLOROTHIAZIDE 167 162* 26 18 43
ENALAPRIL MALEATE 156 151* 23 19 42
ALLOPURINOL 152 138 19 20 25
CRESTOR 138 133* 19 21 27
GABAPENTIN 138 113 23 21 16
GLIMEPIRIDE 137 121 20 23 38
BISOPROLOL FUMARATE 127 122* 24 24 88
PREDNISONE 122 117* 57 25 36
SPIRIVA 119 106 16 26 67
ADVAIR DISKUS 117 117 16 27 51
METOPROLOL TARTRATE 114 109* 21 28 12
VENLAFAXINE HCL ER 111 89 17 29 73
POLYETHYLENE GLYCOL 3350 111 106* 33 29 29
BYSTOLIC 111 106* 12 29 55
ATENOLOL 108 103* 18 32 22
PIOGLITAZONE HCL 105 81 15 R 33 62
ALPRAZOLAM 101 96* 25 B 34 32
NEXIUM 100 100 14 35 47
FENTANYL 98 98 15 S2 36 46
DONEPEZIL HCL 97 97 15 37 33
PRAVASTATIN SODIUM 95 90* 13 38 21
ZOLPIDEM TARTRATE 93 59 20 39 26
TRAZODONE HCL 91 72 16 40 48
RANITIDINE HCL 91 91 19 40 45
PANTOPRAZOLE SODIUM 90 78 17 42 28
TAMSULOSIN HCL 89 89 12 43 24
CEPHALEXIN 87 82* 51 44 72
CYCLOBENZAPRINE HCL 86 59 23 R 45 80
NAMENDA 86 86 13 45 34
METOPROLOL SUCCINATE 85 85 16 47 13
CLOPIDOGREL 85 85 13 47 30
FLUTICASONE PROPIONATE 77 72* 24 49 39
DIOVAN 77 <11 <11 49 52
AMLODIPINE BESYLATE-BENAZEPRIL 74 <11 <11 51 101
BENAZEPRIL HCL 72 72 12 52 50
VESICARE 71 53 12 53 69
MONTELUKAST SODIUM 71 <11 <11 53 59
ALENDRONATE SODIUM 70 65* 16 55 35
DIGOXIN 69 <11 <11 56 96
CYMBALTA 68 45 11 57 41
DILTIAZEM 24HR ER 67 <11 <11 58 112
FENOFIBRATE* 64 <11 <11 59 60
LANTUS 64 <11 <11 59 53
DIGOX 64 <11 <11 59 116
FAMOTIDINE* 62 50 13 62 66
AVODART 61 <11 <11 63 129
OXYBUTYNIN CHLORIDE ER 61 <11 <11 63 107
LORAZEPAM 60 55* 11 B 65 37
CEFDINIR 60 55* 46 65 159
LANTUS SOLOSTAR 59 <11 <11 67 91
ROPINIROLE HCL 56 <11 <11 68 63
CELEBREX 55 <11 <11 69 61
CLONAZEPAM 54 <11 <11 B 70 54
METFORMIN HCL ER 54 49* 11 70 68
CHLORTHALIDONE 52 <11 <11 72 111
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 <11 <11 72 94
ESCITALOPRAM OXALATE 51 <11 <11 74 40
OXYCODONE-ACETAMINOPHEN 50 45* 14 S2 75 90
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.